Boutis K, Shannon M
Division of Emergency Medicine, Children's Hospital, Boston, Massachusetts 02115, USA.
J Toxicol Clin Toxicol. 2001;39(5):441-5. doi: 10.1081/clt-100105413.
To determine the rate of acetaminophen related nephrotoxicity in adolescents who present after acute severe acetaminophen intoxication and to identify potential predictors of this outcome.
Retrospective analysis of consecutive patients between the ages of 12 and 18 years who were admitted at a tertiary care children's hospital for treatment of acute severe acetaminophen intoxication with N-acetylcysteine. The main outcome measure was the frequency of acetaminophen-related nephrotoxicity, defined as abnormal blood urea nitrogen (>6.4 mmol/L or > 18 mg/dL) and/or elevated creatinine (97.2 micromol/L or > 1.1 mg/dL) in association with one or both of the following: elevated blood pressure (systolic blood pressure > 140 mm Hg/diastolic blood pressure >85) or abnormal urinalysis (urinalysis with hematuria or proteinuria). Statistical analyses used were measures of central tendency, Student's t-test, Mann-Whitney, and multivariate logistic regression.
Fourty-five patients were included. Acetaminophen-related nephrotoxicity occurred in 4 (8.9%) cases. One victim developed severe renal injury in association with elevated hepatic transaminases. Intergroup analyses revealed no statistically significant association between acetaminophen-related nephrotoxicity and amount/kg of acute severe acetaminophen ingested, delay in treatment with N-acetylcysteine, or measures of hepaticfunction.
Acetaminophen-related nephrotoxicity occurred in 8.9% [95% CI: 4.52, 20.48] of children with severe overdose. There are no obvious predictors of this complication of acetaminophen overdose. Because the occurrence of renal injury can not be predicted, serial blood pressure, blood urea nitrogen/creatinine, and urinalysis should be considered an integral part of the management of children with acute, severe acetaminophen intoxication.
确定急性严重对乙酰氨基酚中毒后就诊的青少年中对乙酰氨基酚相关肾毒性的发生率,并确定这一结果的潜在预测因素。
对一家三级儿童专科医院收治的12至18岁连续患者进行回顾性分析,这些患者因急性严重对乙酰氨基酚中毒接受N-乙酰半胱氨酸治疗。主要结局指标是对乙酰氨基酚相关肾毒性的发生率,定义为血尿素氮异常(>6.4 mmol/L或>18 mg/dL)和/或肌酐升高(>97.2 μmol/L或>1.1 mg/dL),并伴有以下一项或两项:血压升高(收缩压>140 mmHg/舒张压>85)或尿液分析异常(血尿或蛋白尿的尿液分析)。所采用的统计分析方法包括集中趋势测量、学生t检验、曼-惠特尼检验和多因素逻辑回归。
纳入45例患者。4例(8.9%)发生对乙酰氨基酚相关肾毒性。1例受害者出现严重肾损伤并伴有肝转氨酶升高。组间分析显示,对乙酰氨基酚相关肾毒性与急性严重对乙酰氨基酚摄入量(mg/kg)、N-乙酰半胱氨酸治疗延迟或肝功能指标之间无统计学显著关联。
严重过量服用对乙酰氨基酚的儿童中,8.9%[95%CI:4.52,20.48]发生对乙酰氨基酚相关肾毒性。对乙酰氨基酚过量的这一并发症没有明显的预测因素。由于无法预测肾损伤的发生,连续监测血压、血尿素氮/肌酐和尿液分析应被视为急性严重对乙酰氨基酚中毒儿童管理的一个组成部分。